Ocular Threpeutix
Biopharmaceutical company focused on therapies for the eye.
Based in MA
🤖
AI Overview
With $160K in lobbying spend across 10 quarterly filings, Ocular Threpeutix is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.
$160K
Total Spend
2
Years Active
1
Firms Hired
4
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $80K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
- •Medicare reimbursement for ocular devices and therapies.
- •Biopharmaceutical company focused on therapies for the eye.
- •Biopharmaceutical company focused on therapies for the eye. Issues related to Medicare reimbursement for therapies of the eye.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.